Citations (202)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (39)
Yicong Bian, Sheng Ma, Qingqing Yao, Tao Hu, Mingjing Ge, Hongting Li, Shansong Zheng, Zheming Gu, Hao Feng, Zhenwen Yu, Chenrong Huang, Hua Zhang, Limei Zhao & Liyan Miao. (2024) Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study. Expert Opinion on Investigational Drugs 33:1, pages 63-72.
Read now
Read now
Lin Xu, Chi-Chi Peng, Kate Dawson, Scott Stecher, James Woodworth & Chandra Prakash. (2023) Metabolism, pharmacokinetics and excretion of [14C]dimethyl fumarate in healthy volunteers: an example of xenobiotic biotransformation following endogenous metabolic pathways. Xenobiotica 53:3, pages 163-172.
Read now
Read now
S. Cyrus Khojasteh, Upendra A. Argikar, Sungjoon Cho, Rachel Crouch, Carley J. S. Heck, Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, Hlaing (Holly) Maw, Herana Kamal Seneviratne, Shuai Wang, Cong Wei, Donglu Zhang & Klarissa D. Jackson. (2022) Biotransformation novel advances – 2021 year in review. Drug Metabolism Reviews 54:3, pages 207-245.
Read now
Read now
Huan Cheng, Jinghua Yu, Chen Yang, Ning Zhang, Zhen Fan, Xiaojuan Zhang, Junchen Wang, Zhen Wang, Da-fang Zhong, Ji-Xiang He, Shu Yan & Xingxing Diao. (2022) Absorption, distribution, metabolism, and excretion of [14C]TPN729 after oral administration to rats. Xenobiotica 52:1, pages 79-90.
Read now
Read now
Nathalie Rioux, Sherri Smith, Federico Colombo, Amy Kim, W. George Lai, Darrell Nix, Y. Amy Siu, Joanne Schindler & Peter G. Smith. (2020) Metabolic disposition of H3B-8800, an orally available small-molecule splicing modulator, in rats, monkeys, and humans. Xenobiotica 50:9, pages 1101-1114.
Read now
Read now
Marie-Laure Boof, Jan Jaap van Lier, Stephen English, Hartmut Fischer, Mike Ufer & Jasper Dingemanse. (2020) Absorption, distribution, metabolism, and excretion of cenerimod, a selective S1P1 receptor modulator in healthy subjects. Xenobiotica 50:8, pages 947-956.
Read now
Read now
Enaksha R. Wickremsinhe, Scott M. Hynes, Christopher D. Payne, Yingying Guo & Kenneth C. Cassidy. (2020) Disposition of [14C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours. Xenobiotica 50:7, pages 793-804.
Read now
Read now
Rocco P. Milluzzo, Gabriele A. Franchina, Davide Capodanno & Dominick J. Angiolillo. (2020) Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development. Expert Opinion on Investigational Drugs 29:6, pages 537-546.
Read now
Read now
Mike Ufer, Christine Huynh, Jan Jaap van Lier, Eva Caroff, Hartmut Fischer & Jasper Dingemanse. (2020) Absorption, distribution, metabolism and excretion of the P2Y12 receptor antagonist selatogrel after subcutaneous administration in healthy subjects. Xenobiotica 50:4, pages 427-434.
Read now
Read now
Kaoru Kobayshi, Yoshikazu Abe, Asuka Kawai, Takao Furihata, Hiroshi Harada, Takuro Endo & Hiroo Takeda. (2019) Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro. Xenobiotica 49:12, pages 1434-1446.
Read now
Read now
David Pearson, Maxime Garnier, Alexandre Luneau, Alexander David James & Markus Walles. (2019) 19F-NMR-based determination of the absorption, metabolism and excretion of the oral phosphatidylinositol-3-kinase (PI3K) delta inhibitor leniolisib (CDZ173) in healthy volunteers. Xenobiotica 49:8, pages 953-960.
Read now
Read now
Shiyao Xu, Dan Tatosian, Ian Mcintosh, Maria Caceres, Catherine Matthews, Koppara Samuel, Diana Selverian, Sanjeev Kumar & Eunkyung Kauh. (2018) Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans. Xenobiotica 48:6, pages 584-591.
Read now
Read now
Kenneth C. Cassidy, Ivelina Gueorguieva, Colin Miles, Jessica Rehmel, Ping Yi & William J. Ehlhardt. (2018) Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics. Xenobiotica 48:4, pages 382-399.
Read now
Read now
Frédéric Lozac'h, Simon Fahrni, Daniele De Maria, Caroline Welte, Joël Bourquin, Hans-Arno Synal, David Pearson, Markus Walles & Gian Camenisch. (2018) Evaluation of cAMS for 14C Microtracer ADME Studies: Opportunities to Change the Current Drug Development Paradigm. Bioanalysis 10:5, pages 321-339.
Read now
Read now
Valérie Mancel, François-Xavier Mathy, Pierre Boulanger, Stephen English, Marie Croft, Christopher Kenney, Tarra Knott, Armel Stockis & Massimo Bani. (2017) Pharmacokinetics and metabolism of [14C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers. Xenobiotica 47:8, pages 705-718.
Read now
Read now
Poonam Giri, Harilal Patel & Nuggehally R Srinivas. (2017) Human Biliary Amount Prediction Using Simple, Bile Flow-Rate Corrected and Uridine Diphosphate Glucuronosyltransferase Activity Corrected Allometric Methods. International Journal of Pharmacokinetics 2:3, pages 173-182.
Read now
Read now
Akifumi Kogame, Toshiyuki Takeuchi, Masami Nonaka, Hitomi Yamasaki, Naohiro Kawaguchi, Ai Bernards, Yoshihiko Tagawa, Akio Morohashi, Takahiro Kondo, Toshiya Moriwaki & Satoru Asahi. (2017) Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs. Xenobiotica 47:3, pages 255-266.
Read now
Read now
Elena Guerini, Simone Schadt, Gerard Greig, Ruth Haas, Christophe Husser, Manfred Zell, Christoph Funk, Thomas Hartung, Andreas Gloge & Navita L. Mallalieu. (2017) A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans. Xenobiotica 47:2, pages 144-153.
Read now
Read now
Stephen Flach, Marie Croft, Jie Ding, Ron Budhram, Todd Pankratz, Mike Pennick, Graeme Scarfe, Steven Troy & Jay Getsy. (2016) Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach. Drug Design, Development and Therapy 10, pages 3125-3132.
Read now
Read now
Kitaw Negash, Clara Andonian, Clive Felgate, Cathy Chen, Igor Goljer, Bianca Squillaci, Dung Nguyen, Jill Pirhalla, Mally Lev, Ernest Schubert, Courtney Tiffany, Mohammad Hossain & May Ho. (2016) The metabolism and disposition of GSK2140944 in healthy human subjects. Xenobiotica 46:8, pages 683-702.
Read now
Read now
C. M. Nijenhuis, J. H. M. Schellens & J. H. Beijnen. (2016) Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review. Drug Metabolism Reviews 48:2, pages 266-280.
Read now
Read now
Le Thuy Vuong, Qi Song, Hee Joo Lee, Ad F Roffel, Seok-Ho Shin, Young G Shin & Stephen R Dueker. (2016) Opportunities in Low-Level Radiocarbon Microtracing: Applications and New Technology. Future Science OA 2:1.
Read now
Read now
Gary David Bowers, Amanda Culp, Melinda J. Reese, Glenn Tabolt, Lee Moss, Stephen Piscitelli, Phuong Huynh, David Wagner, Susan L. Ford, Elizabeth P. Gould, Rennan Pan, Yu Lou, David A. Margolis & William R. Spreen. (2016) Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans. Xenobiotica 46:2, pages 147-162.
Read now
Read now
Haitao Hu, Naijia Huang, Ping Yi, Yu-Hua Hui, Robert D. Dally, William J. Ehlhardt & Palaniappan Kulanthaivel. (2015) Utilizing 19F NMR to investigate drug disposition early in drug discovery. Xenobiotica 45:12, pages 1081-1091.
Read now
Read now
Maribel Reyes, Matthias Hoch, Patrick Brossard, Winfried Wagner-Redeker, Tommaso Miraval & Jasper Dingemanse. (2015) Mass balance, pharmacokinetics and metabolism of the selective S1P1 receptor modulator ponesimod in humans. Xenobiotica 45:2, pages 139-149.
Read now
Read now
Theodore R. Johnson, Weiwei Tan, Lance Goulet, Evan B. Smith, Shinji Yamazaki, Gregory S. Walker, Melissa T. O’Gorman, Gabriella Bedarida, Helen Y. Zou, James G. Christensen, Leslie N. Nguyen, Zhongzhou Shen, Deepak Dalvie, Akintunde Bello & Bill J. Smith. (2015) Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects. Xenobiotica 45:1, pages 45-59.
Read now
Read now
Enaksha R. Wickremsinhe, Scott M. Hynes, Margo D. Palmieri, Malcolm I. Mitchell, Trent L. Abraham, Jessica Fayer Rehmel, Emilie Chana, Lorenz M. Jost & Kenneth C. Cassidy. (2014) Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors. Xenobiotica 44:9, pages 827-841.
Read now
Read now
May Y. K. Ho, Michael J. Morris, Jill L. Pirhalla, John W. Bauman, Carolyn B. Pendry, Keith W. Orford, Royce A. Morrison & Donna S. Cox. (2014) Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers. Xenobiotica 44:4, pages 352-368.
Read now
Read now
David S Wagner, Jill L Pirhalla & Gary D Bowers. (2013) Metabolite Structure Analysis by High-Resolution MS: Supporting Drug-Development Studies. Bioanalysis 5:4, pages 463-479.
Read now
Read now
R. Scott Obach, Angus N. Nedderman & Dennis A. Smith. (2013) A response to “radiolabelled mass-balance excretion and metabolism studies in laboratory animals: a commentary on why they are still necessary”. Xenobiotica 43:2, pages 226-227.
Read now
Read now
Shirin Bruderer, Gérard Hopfgartner, Michael Seiberling, Janine Wank, Patricia N. Sidharta, Alexander Treiber & Jasper Dingemanse. (2012) Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans. Xenobiotica 42:9, pages 901-910.
Read now
Read now
Leif D Svensson. (2012) Could Traditional Mass-Balance Studies in The ‘Twilight Zone’ Be Improved By Means of Accelerator Ms Measurements?. Bioanalysis 4:15, pages 1835-1837.
Read now
Read now
Debra Luffer-Atlas. (2012) The early estimation of circulating drug metabolites in humans. Expert Opinion on Drug Metabolism & Toxicology 8:8, pages 985-997.
Read now
Read now
Graham Lappin, Mark Seymour, Gerhard Gross, Martin J⊘rgensen, Morten Kall & Lisbet Kværn⊘. (2012) Meeting The Mist Regulations: Human Metabolism in Phase I Using Ams And A Tiered Bioanalytical Approach. Bioanalysis 4:4, pages 407-416.
Read now
Read now
Mario Pellegatti. (2012) Preclinical in vivo ADME studies in drug development: a critical review. Expert Opinion on Drug Metabolism & Toxicology 8:2, pages 161-172.
Read now
Read now
R. Scott Obach, Angus N. Nedderman & Dennis A. Smith. (2012) Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary?. Xenobiotica 42:1, pages 46-56.
Read now
Read now
Angus N.R. Nedderman, Gordon J. Dear, Stephanie North, R. Scott Obach & David Higton. (2011) From definition to implementation: a cross-industry perspective of past, current and future MIST strategies. Xenobiotica 41:8, pages 605-622.
Read now
Read now
Stephen R Dueker, Peter N Lohstroh, Jason A Giacomo, Le T Vuong, Bradly D Keck & John S Vogel. (2010) Early Human ADME Using Microdoses and Microtracers: Bioanalytical Considerations. Bioanalysis 2:3, pages 441-454.
Read now
Read now
Y. Pan, H.-C. Bi, G.-P. Zhong, X. Chen, Z. Zuo, L.-Z. Zhao, L.-Q. Gu, P.-Q. Liu, Z.-Y. Huang, S.-F. Zhou & M. Huang. (2008) Pharmacokinetic characterization of hydroxylpropyl-β-cyclodextrin-included complex of cryptotanshinone, an investigational cardiovascular drug purified from Danshen (). Xenobiotica 38:4, pages 382-398.
Read now
Read now
Articles from other publishers (163)
Zhengping Hu, Wenyan Wang, Huijie Yang, Fengjuan Zhao, Chunjie Sha, Wei Mi, Shuying Yin, Hongbo Wang, Jingwei Tian & Liang Ye. (2024) Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7–16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson’s Disease. Molecules 29:10, pages 2184.
Crossref
Crossref
Susanne Bonsmann, David McCormick, Jörg Pausch, Michiel de Vries, Melanie Sumner, Alexander Birkmann, Holger Zimmermann & Dirk Kropeit. (2024) Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects. Clinical Pharmacology in Drug Development 13:4, pages 389-403.
Crossref
Crossref
Gi Beom Kim, Jeong In Seo, Myung Chan Gye & Hye Hyun Yoo. (2024) Isosorbide, a versatile green chemical: Elucidating its ADME properties for safe use. Ecotoxicology and Environmental Safety 272, pages 116051.
Crossref
Crossref
Jim Vrbanac & Ric Slauter. 2024. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
49
82
.
Shuai Wang, T. Eric Ballard, Lisa J. Christopher, Robert S. Foti, Chungang Gu, S. Cyrus Khojasteh, Joyce Liu, Shuguang Ma, Bin Ma, R. Scott Obach, Simone Schadt, Zhoupeng Zhang & Donglu Zhang. (2023) The Importance of Tracking “Missing” Metabolites: How and Why?. Journal of Medicinal Chemistry 66:23, pages 15586-15612.
Crossref
Crossref
Mirko Koziolek, Patrick Augustijns, Constantin Berger, Rodrigo Cristofoletti, David Dahlgren, Janneke Keemink, Pär Matsson, Fiona McCartney, Marco Metzger, Mario Mezler, Janis Niessen, James E. Polli, Maria Vertzoni, Werner Weitschies & Jennifer Dressman. (2023) Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics 15:10, pages 2397.
Crossref
Crossref
Ikuo Yamamiya, Allen Hunt, Fumiaki Yamashita, Daryl Sonnichsen, Toshiharu Muto, Yaohua He & Karim A. Benhadji. (2023) Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants. Clinical Pharmacology in Drug Development 12:9, pages 927-939.
Crossref
Crossref
Daniel Grau, Nicole Grau, Christian Paroissin, Quentin Gascuel & Julie Di Cristofaro. (2023) Underestimation of glyphosate intake by the methods currently used by regulatory agencies. Environmental Science and Pollution Research 30:45, pages 100626-100637.
Crossref
Crossref
William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter & Thomas A. Baillie. (2023) Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment. Drug Metabolism and Disposition 51:6, pages 753-763.
Crossref
Crossref
Caroline A. Lee, D. Alexander Oh, Yong Tang, Ping Yi, Mohammad Bashir, Stephen English, Marie Croft, Anthony Blackburn, Steve Bloom, Kye Gilder & John S. Grundy. (2023) Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism. Clinical Pharmacology in Drug Development 12:6, pages 553-571.
Crossref
Crossref
Chandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg, Maria Heijer, Jingjing Yan, Linda C. Andersson, Ulrik Jurva, Marta Pelay-Gimeno, Wouter H.J. Vaes, Rianne A.F. de Ligt, Malin Gränfors, Carl Amilon, Eva-Lotte Lindstedt, Somasekhara R. Menakuru, Pavlo Garkaviy, Lars Weidolf & V. Sashi Gopaul. (2023) Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans. Drug Metabolism and Disposition 51:4, pages 451-463.
Crossref
Crossref
Matthew A. Cerny, Douglas K Spracklin & R. Scott Obach. (2023) Human Absorption, Distribution, Metabolism and Excretion Studies - Origins, Innovations and Importance. Drug Metabolism and Disposition, pages DMD-MR-2022-001006.
Crossref
Crossref
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development
137
174
.
Lei He, Donglin Feng, Hui Guo, Yueyuan Zhou, Zhaozhao Li, Kuo Zhang, Wangqian Zhang, Shuning Wang, Zhaowei Wang, Qiang Hao, Cun Zhang, Yuan Gao, Jintao Gu, Yingqi Zhang, Weina Li & Meng Li. (2022) Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology 13.
Crossref
Crossref
ZHENG YANG. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
103
141
.
Ravi Shankar P. Singh, Gregory S. Walker, Eugene P. Kadar, Loretta M. Cox, Heather Eng, Raman Sharma, Arthur J. Bergman, Lien Van Eyck, Frances Hackman, Sima S. Toussi, Amit S. Kalgutkar & R. Scott Obach. (2022) Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Clinical Pharmacology & Therapeutics 112:6, pages 1201-1206.
Crossref
Crossref
Bo Wen, Ying Zhang, Graeme C. Young, David Kenworthy, Adrian Pereira, Jill Pirhalla, Janine Doyle, Bethany Jordon, Joyce Zhan & Mark Johnson. (2022) Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling. Drug Metabolism and Disposition 50:11, pages 1442-1453.
Crossref
Crossref
Anuradha Ramamoorthy, Girish Bende, Edwin Chiu Yuen Chow, Hristina Dimova, Neil Hartman, Daphney Jean, Sonia Pahwa, Yunzhao Ren, Chinmay Shukla, Yuching Yang, Suresh Doddapaneni & Zhixia Yan Danielsen. (2022)
Human radiolabeled mass balance studies supporting the
FDA
approval of new drugs
. Clinical and Translational Science 15:11, pages 2567-2575.
Crossref
Crossref
Ana I. Loureiro, Francisco Rocha, Ana T. Santos, Nand Singh, Maria João Bonifácio, Rui Pinto, Laszlo E. Kiss & Patrício Soares‐da‐Silva. (2022) Absorption, metabolism and excretion of opicapone in human healthy volunteers. British Journal of Clinical Pharmacology 88:10, pages 4540-4551.
Crossref
Crossref
Irene Vuu, Upendra P. Dahal, Zhe Wang, Xiaomeng Shen, John Rodgers, Jan Wahlstrom & Brett Houk. (2022) Absorption, metabolism and excretion of [14C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate. Cancer Chemotherapy and Pharmacology 90:4, pages 357-367.
Crossref
Crossref
Daniel Beene, Philip Collender, Andres Cardenas, Charles Harvey, Linden Huhmann, Yan Lin, Johnnye Lewis, Nancy LoIacono, Ana Navas-Acien, Anne Nigra, Craig Steinmaus & Alexander van Geen. (2022) A mass-balance approach to evaluate arsenic intake and excretion in different populations. Environment International 166, pages 107371.
Crossref
Crossref
Haijing Yang, Min Zhang, Yuancheng Chen, Hong Ren, Hong Zhang, Chen Yu, Jianda Lu, Li You, Jicheng Yu, Hong Liang, Cuilan Xiao, Zishuang He, Jufang Wu, Jun Xue & Jing Zhang. (2022) Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment. European Journal of Clinical Pharmacology 78:7, pages 1079-1086.
Crossref
Crossref
Ravi Shankar P. Singh, Martin E. Dowty, Mikhail Salganik, Joanne I. Brodfuehrer, Gregory S. Walker, Raman Sharma, Jean S. Beebe & Spencer I. Danto. (2022)
A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a
14
C‐Microtracer Approach
. Clinical Pharmacology in Drug Development 11:7, pages 815-825.
Crossref
Crossref
Victor Babin, Frédéric Taran & Davide Audisio. (2022) Late-Stage Carbon-14 Labeling and Isotope Exchange: Emerging Opportunities and Future Challenges. JACS Au 2:6, pages 1234-1251.
Crossref
Crossref
Markus Walles, Michael Berna, Wenying Jian, Simon Hauri, Shawna Hengel, Lloyd King, John C. Tran, Cong Wei, Keyang Xu & Xiaochun Zhu. (2022) A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation. Drug Metabolism and Disposition 50:6, pages 846-857.
Crossref
Crossref
Sandeepraj Pusalkar, Swapan K. Chowdhury, Richard Czerniak, Xiaochun Zhu, Yuexian Li, Suresh K. Balani & Diane Ramsden. (2022) Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist. European Journal of Drug Metabolism and Pharmacokinetics 47:3, pages 371-386.
Crossref
Crossref
P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens & J.H. Beijnen. (2022) Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients. Drug Metabolism and Disposition 50:4, pages 327-340.
Crossref
Crossref
Christine Huynh, Swen Seeland, Jerome Segrestaa, Carmela Gnerre, Jens Hogeback, Henriette E. Meyer zu Schwabedissen, Jasper Dingemanse & Patricia N. Sidharta. (2022) Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist: In Vitro, Preclinical, and Clinical Data. Frontiers in Pharmacology 13.
Crossref
Crossref
Ad Roffel, Jan Jaap van Lier, Gerk Rozema & Ewoud-Jan van Hoogdalem. (2022) Predictability of Elimination and Excretion of Small Molecules in Animals
and Humans, and its Impact on Dosimetry for human ADME Studies with
Radiolabeled Drugs. Current Reviews in Clinical and Experimental Pharmacology 17:1, pages 26-38.
Crossref
Crossref
Ann Aurell Holmberg, Lars Weidolf, Sofia Necander, Peter Bold, Sharan Sidhu, Marta Pelay-Gimeno, Rianne A. F. de Ligt, Elwin R. Verheij, Alexandra Jauhiainen, Ioannis Psallidas, Ulrika Wählby Hamrén & Susanne Prothon. (2022) Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects. Drug Metabolism and Disposition 50:2, pages 150-157.
Crossref
Crossref
Ellen Cannady, Kishore Katyayan & Nita Patel. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
51
76
.
Pablo A. M. Quiroga. 2022. The ADME Encyclopedia. The ADME Encyclopedia
117
124
.
Sonja Sturm, Christina Högner, Christoph Seger & Hermann Stuppner. (2021) Combining HPLC-DAD-QTOF-MS and HPLC-SPE-NMR to Monitor In Vitro Vitetrifolin D Phase I and II Metabolism. Metabolites 11:8, pages 529.
Crossref
Crossref
Sekhar Surapaneni, Usha Yerramilli, April Bai, Deepak Dalvie, Jennifer Brooks, Xiaomin Wang, Julie V. Selkirk, Yingzhuo Grace Yan, Peijin Zhang, Richard Hargreaves, Gondi Kumar, Maria Palmisano & Jonathan Q. Tran. (2021) Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator. Drug Metabolism and Disposition 49:5, pages 405-419.
Crossref
Crossref
Alexander J. Stevens, Jerry L. CampbellJrJr, Kim Z. Travis, Harvey J. ClewellIIIIII, Paul M. Hinderliter, Philip A. Botham, Andrew R. Cook, Daniel J. Minnema & Douglas C. Wolf. (2021) Paraquat pharmacokinetics in primates and extrapolation to humans. Toxicology and Applied Pharmacology 417, pages 115463.
Crossref
Crossref
Xiaofei Zhou, Farhad Sedarati, Douglas V. Faller, Dan Zhao, Hélène M. Faessel, Swapan Chowdhury, Jayaprakasam Bolleddula, Yuexian Li, Karthik Venkatakrishnan & Zsuzsanna Papai. (2020) Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors. Investigational New Drugs 39:2, pages 488-498.
Crossref
Crossref
Claudia Miranda, Alexis Aceituno, Mirna Fernández, Gustavo Mendes, Yanina Rodríguez, Verónica Llauró & Miguel Ángel Cabrera-Pérez. (2021) ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries. Pharmaceutics 13:3, pages 363.
Crossref
Crossref
Manfred Schudok, Heiner Glombik & Volker Derdau. (2020)
The magic of small structure differences in a sodium‐glucose cotransporter drug discovery project—
14
C‐labelled drug candidates in a key‐differentiating study
. Journal of Labelled Compounds and Radiopharmaceuticals 64:2, pages 73-76.
Crossref
Crossref
Anhye Kim, Stephen R. Dueker, Jun Gi Hwang, Jangsoo Yoon, Sang‐Won Lee, Hye Suk Lee, Byung‐Yong Yu, Kyung‐Sang Yu & Howard Lee. (2020) An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans. Clinical and Translational Science 14:1, pages 231-238.
Crossref
Crossref
Pablo A. M. Quiroga. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
8
.
Karen Rowland Yeo & Karthik Venkatakrishnan. (2020) Physiologically‐Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study. Clinical Pharmacology & Therapeutics 109:1, pages 51-54.
Crossref
Crossref
David L. Bourdet, Suresh Yeola, Sharath S. Hegde, Pierre-Jean Colson, Chris N. Barnes & Marie T. Borin. (2020) Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite. Drug Metabolism and Disposition 48:12, pages 1312-1320.
Crossref
Crossref
. 2020. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables.
Daria Stypinski, Luke Fostvedt, Justine L. Lam, Alfin Vaz, Theodore R. Johnson, Jan S. Boerma & Yazdi K. Pithavala. (2020) Metabolism, Excretion, and Pharmacokinetics of Lorlatinib (PF‐06463922) and Evaluation of the Impact of Radiolabel Position and Other Factors on Comparability of Data Across 2 ADME Studies. The Journal of Clinical Pharmacology 60:9, pages 1254-1267.
Crossref
Crossref
Anshul Kumar, Rohit Bhatia, Pooja Chawla, Durgadas Anghore, Vipin Saini & Ravindra K. Rawal. (2020) Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma. Anti-Cancer Agents in Medicinal Chemistry 20:10, pages 1158-1172.
Crossref
Crossref
Kishore Katyayan, Ping Yi, Scott Monk & Kenneth Cassidy. (2020)
Excretion, Mass Balance, and Metabolism of [
14
C]LY3202626 in Humans: An Interplay of Microbial Reduction, Reabsorption, and Aldehyde Oxidase Oxidation That Leads to an Extended Excretion Profile
. Drug Metabolism and Disposition 48:8, pages 698-707.
Crossref
Crossref
Ken Ogasawara, Christine Xu, Vanaja Kanamaluru, Nicholas Siebers, Sekhar Surapaneni, Laurence Ridoux, Maria Palmisano & Gopal Krishna. (2020) Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects. Cancer Chemotherapy and Pharmacology 86:2, pages 307-314.
Crossref
Crossref
Douglas K. Spracklin, Danny Chen, Arthur J. Bergman, Ernesto Callegari & R. Scott Obach. (2020) Mini‐Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study. CPT: Pharmacometrics & Systems Pharmacology 9:8, pages 428-434.
Crossref
Crossref
Sudhakar M. Pai, Jeffrey Connaire, Hiroyuki Yamada, Seiji Enya, Barbara Gerhardt, Michihide Maekawa, Hiromasa Tanaka, Ryosuke Koretomo & Tomohiro Ishikawa. (2019)
A Mass Balance Study of
14
C‐Labeled JTZ‐951 (Enarodustat), a Novel Orally Available Erythropoiesis‐Stimulating Agent, in Patients With End‐Stage Renal Disease on Hemodialysis
. Clinical Pharmacology in Drug Development 9:6, pages 728-741.
Crossref
Crossref
Alexander D. James, Hilmar Schiller, Cyrille Marvalin, Yi Jin, Hubert Borell, Ad F. Roffel, Ulrike Glaenzel, Yan Ji & Gian Camenisch. (2020) An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data. Pharmacology Research & Perspectives 8:3.
Crossref
Crossref
Sandeepraj Pusalkar, Xiaofei Zhou, Yuexian Li, Lawrence Cohen, Jun Johnny Yang, Suresh K. Balani, Cindy Xia, Wen Chyi Shyu, Chuang Lu, Karthik Venkatakrishnan & Swapan K. Chowdhury. (2020)
Biotransformation Pathways and Metabolite Profiles of Oral [
14
C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
. Drug Metabolism and Disposition 48:3, pages 217-229.
Crossref
Crossref
Tingting Lai, Yichao Mao, Wei Wang, Xieqing Wang, Naixin Wang & Zelong Liu. (2020) Characterization of basic nitrogen compounds isolated with FeCl3 in vacuum gas oil and its hydrotreated product. Fuel 262, pages 116523.
Crossref
Crossref
Jia Hui Wang, Ke Qi Chen, Jun Xing Jiang, Huan Yong Li, Jun Ping Pan, Ji Yan Su, Lin Wang, Yang Hu, Xiang Nan Mi, Yi Rong Xin, Qin Gao, Xiang Long Zhao, Fei Xiao & Huan Min Luo. (2019) Excretion, Metabolism and Cytochrome P450 Inhibition of Methyl 3,4-Dihydroxybenzoate (MDHB): A Potential Candidate to Treat Neurodegenerative Diseases. European Journal of Drug Metabolism and Pharmacokinetics 45:1, pages 51-69.
Crossref
Crossref
Philip Bransford, Jack Cook, Manish Gupta, Sebastian Haertter, Handan He, Rob Ju, Jitendra Kanodia, Hans Lennernäs, David Lindley, James E. Polli, Larissa Wenning & Yunhui Wu. (2020) ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ Consortium. Molecular Pharmaceutics.
Crossref
Crossref
Jens Atzrodt, Volker Derdau & Claudia Loewe. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
807
825
.
Andrew W. Harrell, Robert Wilson, Yau Lun Man, Kylie Riddell, Emily Jarvis, Graeme Young, Robert Chambers, Lee Crossman, Alex Georgiou, Adrian Pereira, David Kenworthy, Claire Beaumont, Miriam Marotti, Denisa Wilkes, Edith M. Hessel & William A. Fahy. (2019) An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects. Drug Metabolism and Disposition 47:12, pages 1457-1468.
Crossref
Crossref
Paola Coppola, Anita Andersson & Susan Cole. (2019) The Importance of the Human Mass Balance Study in Regulatory Submissions. CPT: Pharmacometrics & Systems Pharmacology 8:11, pages 792-804.
Crossref
Crossref
Shotaro Miura, Koichiro Fukuda, Shinichi Masada, Hirotsugu Usutani, Makoto Kanematsu, David G. Cork & Tetsuji Kawamoto. (2019)
Rapid and efficient synthesis of a novel cholinergic muscarinic M
1
receptor positive allosteric modulator using flash chemistry
. Organic & Biomolecular Chemistry 17:35, pages 8166-8174.
Crossref
Crossref
Matthew W. McCarthy. (2019) Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline. Clinical Pharmacokinetics 58:9, pages 1149-1153.
Crossref
Crossref
Yanke Yu, Chin‐Hee Chung, Anna Plotka, Kevin Quinn, Haihong Shi, Zsuzsanna Pápai, Linh Nguyen & Diane Wang. (2019)
A Phase 1 Mass Balance Study of
14
C‐Labeled Talazoparib in Patients With Advanced Solid Tumors
. The Journal of Clinical Pharmacology 59:9, pages 1195-1203.
Crossref
Crossref
David Dahlgren & Hans Lennernäs. (2019) Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches. Pharmaceutics 11:8, pages 411.
Crossref
Crossref
Ryan H. Takahashi, Jae H. Chang, Jodie Pang, Xiaorong Liang & Shuguang Ma. (2019) Unequal Absorption of Radiolabeled and Nonradiolabeled Drug from the Oral Dose Leads to Incorrect Estimates of Drug Absorption and Circulating Metabolites in a Mass Balance Study. Drug Metabolism Letters 13:1, pages 37-44.
Crossref
Crossref
Sandeepraj Pusalkar, Mihaela Plesescu, Neeraj Gupta, Michael Hanley, Karthik Venkatakrishnan, Jing-Tao Wu, Cindy Xia, Xiaoquan Zhang & Swapan Chowdhury. (2018) Biotransformation of [14C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces. Cancer Chemotherapy and Pharmacology 82:5, pages 803-814.
Crossref
Crossref
Claire Ambery, Graeme Young, Teresa Fuller, Aili L. Lazaar, Adrian Pereira, Adam Hughes, David Ramsay, Frans van den Berg & Peter Daley‐Yates. (2018)
Pharmacokinetics, Excretion, and Mass Balance of [
14
C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men
. Clinical Pharmacology in Drug Development 7:8, pages 901-910.
Crossref
Crossref
Vanessa Tomé, Mário Calvete, Carolina Vinagreiro, Rafael Aroso & Mariette Pereira. (2018) A New Tool in the Quest for Biocompatible Phthalocyanines: Palladium Catalyzed Aminocarbonylation for Amide Substituted Phthalonitriles and Illustrative Phthalocyanines Thereof. Catalysts 8:10, pages 480.
Crossref
Crossref
Neeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, Mihaela Plesescu, Swapan Chowdhury, Michael J. Hanley, Bingxia Wang, Cindy Xia, Xiaoquan Zhang, Karthik Venkatakrishnan & Dale R. Shepard. (2017) A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors. Investigational New Drugs 36:3, pages 407-415.
Crossref
Crossref
René Maltais, Alexandre Trottier, Jenny Roy, Diana Ayan, Nicolas Bertrand & Donald Poirier. (2018) Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments. The Journal of Steroid Biochemistry and Molecular Biology 178, pages 167-176.
Crossref
Crossref
Jim Zheng, Yan Xin, Jingyu Zhang, Raju Subramanian, Bernard P. Murray, J. Andrew Whitney, Matthew R. Warr, John Ling, Lisa Moorehead, Ellen Kwan, Jeffrey Hemenway, Bill J. Smith & Jeffrey A. Silverman. (2018) Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development. Drug Metabolism and Disposition 46:3, pages 237-247.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences. Angewandte Chemie International Edition 57:7, pages 1758-1784.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angewandte Chemie 130:7, pages 1774-1802.
Crossref
Crossref
Arnold Donkor Forkuo, Charles Ansah, David Pearson, Werner Gertsch, Amanda Cirello, Adam Amaral, Jaimie Spear, Colin W. Wright & Caroline Rynn. (2017) Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats. BMC Pharmacology and Toxicology 18:1.
Crossref
Crossref
Michael Gerisch, Thomas Schwarz, Dieter Lang, Gabriele Rohde, Stefanie Reif, Isabelle Genvresse, Susanne Reschke, Dorina van der Mey & Camille Granvil. (2017) Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers. Cancer Chemotherapy and Pharmacology 80:3, pages 535-544.
Crossref
Crossref
Alexander David James, Cyrille Marvalin, Alexandre Luneau, Axel Meissner & Gian Camenisch. (2017)
Comparison of
19
F NMR and
14
C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in Humans
. Drug Metabolism and Disposition 45:8, pages 900-907.
Crossref
Crossref
C.M. Nijenhuis, L. Lucas, H. Rosing, A.D.R. Huitema, M. Mergui-Roelvink, G. C. Jamieson, J.A. Fox, D.R. Mould, J.H.M. Schellens & J.H. Beijnen. (2017) Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II. Investigational New Drugs 35:4, pages 478-490.
Crossref
Crossref
Mika Sato-Nakai, Kosuke Kawashima, Toshito Nakagawa, Yukako Tachibana, Miyuki Yoshida, Kenji Takanashi, Peter N. Morcos, Martin Binder, David J Moore & Li Yu. (2017) Metabolites of alectinib in human: their identification and pharmacological activity. Heliyon 3:7, pages e00354.
Crossref
Crossref
Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein & Tycho Heimbach. (2017) Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug. Drug Metabolism and Disposition 45:5, pages 540-555.
Crossref
Crossref
Raju Subramanian, Xiaochun Zhu, M. Benjamin Hock, Bethlyn J. Sloey, Benjamin Wu, Sarah F. Wilson, Ogo Egbuna, J. Greg Slatter, Jim Xiao & Gary L. Skiles. (2016) Pharmacokinetics, Biotransformation, and Excretion of [14C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on Hemodialysis. Clinical Pharmacokinetics 56:2, pages 179-192.
Crossref
Crossref
Liviawati Wu, Murad Melhem, Raju Subramanian & Benjamin Wu. (2017) Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis. Journal of Pharmacokinetics and Pharmacodynamics 44:1, pages 43-53.
Crossref
Crossref
Yu-Luan Chen, Estela Skende, Jing Lin, Yijun Yi, Peter L. Wang, Sarah Wills, H. Scott Wilkinson, Kenneth S. Koblan & Seth C. Hopkins. (2017)
Absorption, distribution, metabolism, and excretion of [
14
C]-dasotraline in humans
. Pharmacology Research & Perspectives 5:1, pages e00281.
Crossref
Crossref
Wen Lin, Jimmy Flarakos, Yancy Du, Wenyu Hu, Handan He, James Mangold, S. Ken Tanaka & Stephen Villano. (2017)
Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of
14
C-Omadacycline in Rats
. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
J. Vrbanac & R. Slauter. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
39
67
.
R.E. White. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
1
33
.
Roger K. Verbeeck & Joëlle Warlin. 2017. Bioequivalence Requirements in Various Global Jurisdictions. Bioequivalence Requirements in Various Global Jurisdictions
75
100
.
Jens Atzrodt, Volker Derdau & Claudia Loewe. 2017. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
19
.
A.F. Roffel, S.P. van Marle, J.J. van Lier, J. Hartstra & E.‐J. van Hoogdalem. (2016) An evaluation of human ADME and mass balance studies using regular or low doses of radiocarbon. Journal of Labelled Compounds and Radiopharmaceuticals 59:14, pages 619-626.
Crossref
Crossref
Gordon J. Dear & Andrew McEwen. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
45
85
.
Gordon J. Dear & Angus N. R. Nedderman. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
17
43
.
Dora Babu Madhura, Ashit Trivedi, Jiuyu Liu, Vincent A. Boyd, Cynthia Jeffries, Vivian Loveless, Richard E. Lee & Bernd Meibohm. (2016) Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis. The AAPS Journal 18:3, pages 788-791.
Crossref
Crossref
Ajit Suri, Sandeepraj Pusalkar, Yuexian Li & Shimoga Prakash. (2016) Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK‐700) in Healthy Male Subjects: A Phase 1, Open‐Label, Single‐Dose Study. Clinical Pharmacology in Drug Development 5:3, pages 180-187.
Crossref
Crossref
Nigel J. Waters, Sherri A. Smith, Edward J. Olhava, Kenneth W. Duncan, Richard D. Burton, James O’Neill, Marie-Eve Rodrigue, Roy M. Pollock, Mikel P. Moyer & Richard Chesworth. (2015) Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human. Cancer Chemotherapy and Pharmacology 77:1, pages 43-62.
Crossref
Crossref
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Crossref
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy
111
138
.
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy
37
62
.
Lars Dalgaard. (2015) Comparison of minipig, dog, monkey and human drug metabolism and disposition. Journal of Pharmacological and Toxicological Methods 74, pages 80-92.
Crossref
Crossref
Ari Tolonen & Olavi Pelkonen. (2015) Analytical challenges for conducting rapid metabolism characterization for QIVIVE. Toxicology 332, pages 20-29.
Crossref
Crossref
Li Di & R. Scott Obach. (2015) Addressing the Challenges of Low Clearance in Drug Research. The AAPS Journal 17:2, pages 352-357.
Crossref
Crossref
Carrie A. Morris, Stephen R. Dueker, Peter N. Lohstroh, Li-Quan Wang, Xin-Ping Fang, Donald Jung, Luis Lopez-Lazaro, Mark Baker, Stephan Duparc, Isabelle Borghini-Fuhrer, Rolf Pokorny, Jang-Sik Shin & Lawrence Fleckenstein. (2014) Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics 40:1, pages 75-86.
Crossref
Crossref
Supannee Pruksa, Atitaya Siripinyanond, Jonathan J Powell & Ravin Jugdaohsingh. (2014) Silicon balance in human volunteers; a pilot study to establish the variance in silicon excretion versus intake. Nutrition & Metabolism 11:1.
Crossref
Crossref
Claire Beaumont, Graeme C. Young, Tom Cavalier & Malcolm A. Young. (2014) Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. British Journal of Clinical Pharmacology 78:6, pages 1185-1200.
Crossref
Crossref
Thomas G. Gant. (2013) Using Deuterium in Drug Discovery: Leaving the Label in the Drug. Journal of Medicinal Chemistry 57:9, pages 3595-3611.
Crossref
Crossref
Ryan Takahashi, Shuguang Ma, Alan Deese, Qin Yue, Heasook Kim-Kang, Yijun Yi, Michael Siu, Kevin W. Hunt, Nicholas C. Kallan, Cornelis E.C.A. Hop, Xingrong Liu & S. Cyrus Khojasteh. (2014) Elucidating the Mechanism of Cytochrome P450–Mediated Pyrimidine Ring Conversion to Pyrazole Metabolites with the BACE1 Inhibitor GNE-892 in Rats. Drug Metabolism and Disposition 42:5, pages 890-898.
Crossref
Crossref
Bill J. Smith, Yazdi Pithavala, Hai-Zhi Bu, Ping Kang, Brian Hee, Alan J. Deese, William F. Pool, Karen J. Klamerus, Ellen Y. Wu & Deepak K. Dalvie. (2014)
Pharmacokinetics, Metabolism, and Excretion of [
14
C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans
. Drug Metabolism and Disposition 42:5, pages 918-931.
Crossref
Crossref
Lishan Lin, Cen Xie, Zhiwei Gao, Xiaoyan Chen & Dafang Zhong. (2014) Metabolism and Pharmacokinetics of Allitinib in Cancer Patients: The Roles of Cytochrome P450s and Epoxide Hydrolase in its Biotransformation. Drug Metabolism and Disposition 42:5, pages 872-884.
Crossref
Crossref
Mehul Dave, Mike Nash, Graeme C. Young, Harma Ellens, Mindy H. Magee, Andrew D. Roberts, Maxine A. Taylor, Robert W. Greenhill & Gary W. Boyle. (2014) Disposition and Metabolism of Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Humans. Drug Metabolism and Disposition 42:3, pages 415-430.
Crossref
Crossref
W. Griffith Humphreys. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
10
.
Eric G. Solon & Brian R. Moyer. 2014. Pharmaco-Imaging in Drug and Biologics Development. Pharmaco-Imaging in Drug and Biologics Development
133
185
.
Yong Zhang, Matthew P. Sadgrove, Russell J. Mumper & Michael Jay. (2013) Radionuclide Decorporation: Matching the Biokinetics of Actinides by Transdermal Delivery of Pro-chelators. The AAPS Journal 15:4, pages 1180-1188.
Crossref
Crossref
Andrew V. Stachulski, Thomas A. Baillie, B. Kevin Park, R. Scott Obach, Deepak K. Dalvie, Dominic P. Williams, Abhishek Srivastava, Sophie L. Regan, Daniel J. Antoine, Christopher E. P. Goldring, Alvin J. L. Chia, Neil R. Kitteringham, Laura E. Randle, Hayley Callan, J. Luis Castrejon, John Farrell, Dean J. Naisbitt & Martin S. Lennard. (2013) The Generation, Detection, and Effects of Reactive Drug Metabolites. Medicinal Research Reviews 33:5, pages 985-1080.
Crossref
Crossref
Eva Montané, Anna López & Joan Costa. (2013) Características y diseño de los estudios que evalúan interacciones farmacológicas. Medicina Clínica 141:2, pages 82-86.
Crossref
Crossref
Christopher B. Lietz, Erin Gemperline & Lingjun Li. (2013) Qualitative and quantitative mass spectrometry imaging of drugs and metabolites. Advanced Drug Delivery Reviews 65:8, pages 1074-1085.
Crossref
Crossref
T.-H. Lin, K. Hu, J. Flarakos, M. Sharr-McMahon, J. B. Mangold, H. He & Y. Wang. (2013) Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry. Cancer Chemotherapy and Pharmacology 72:1, pages 181-188.
Crossref
Crossref
Dietmar Schwab, Agnes Portron, Zoe Backholer, Berthold Lausecker & Kosuke Kawashima. (2013) A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans. Clinical Pharmacokinetics 52:6, pages 463-473.
Crossref
Crossref
Cho-Ming Loi, Dennis A. Smith & Deepak Dalvie. (2013) Which Metabolites Circulate?. Drug Metabolism and Disposition 41:5, pages 933-951.
Crossref
Crossref
Ying Yng Choy, Grayson K. Jaggers, Patricia I. Oteiza & Andrew L. Waterhouse. (2012) Bioavailability of Intact Proanthocyanidins in the Rat Colon after Ingestion of Grape Seed Extract. Journal of Agricultural and Food Chemistry 61:1, pages 121-127.
Crossref
Crossref
Andrew W. Harrell, Sarah K. Siederer, Jo Bal, Nainesh H. Patel, Graeme C. Young, Clive C. Felgate, Sebastian J. Pearce, Andy D. Roberts, Claire Beaumont, Amanda J. Emmons, Adrian I. Pereira & Rodger D. Kempsford. (2013)
Metabolism and Disposition of Vilanterol, a Long-Acting
β
2
-Adrenoceptor Agonist for Inhalation Use in Humans
. Drug Metabolism and Disposition 41:1, pages 89-100.
Crossref
Crossref
Jim Vrbanac & Richard Slauter. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
3
30
.
David Saunders, Phisit Khemawoot, Pattaraporn Vanachayangkul, Raveewan Siripokasupkul, Delia Bethell, Stuart Tyner, Youry Se, Wiriya Rutvisuttinunt, Sabaithip Sriwichai, Lon Chanthap, Jessica Lin, Ans Timmermans, Doung Socheat, Pascal Ringwald, Harald Noedl, Bryan Smith, Mark Fukuda & Paktiya Teja-isavadharm. (2012) Pharmacokinetics and Pharmacodynamics of Oral Artesunate Monotherapy in Patients with Uncomplicated Plasmodium falciparum Malaria in Western Cambodia. Antimicrobial Agents and Chemotherapy 56:11, pages 5484-5493.
Crossref
Crossref
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
225
240
.
Alexander V. LyubimovKarthik Venkatakrishnan. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
62
.
Alexander V. LyubimovSteven Zhang. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
37
.
Alexander V. LyubimovTsuhan Lin, Tycho Heimbach, Rakesh Gollen & Handan He. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
39
.
Alexander V. LyubimovRonald E. White. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Monette M. Cotreau, Christine L. Hale, Lindsey Jacobson, Claudine S. Oelke, Andrew L. Strahs, Robert G. Kochan, Madhu Sanga, William Slichenmyer & Dennis L. Vargo. (2013)
Absorption, Metabolism, and Excretion of [
14
C]‐Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Male Participants: A Phase I, Open‐Label, Mass‐Balance Study
. Clinical Pharmacology in Drug Development 1:3, pages 102-109.
Crossref
Crossref
Arik Dahan, Hans Lennernäs & Gordon L. Amidon. (2012) The Fraction Dose Absorbed, in Humans, and High Jejunal Human Permeability Relationship. Molecular Pharmaceutics 9:6, pages 1847-1851.
Crossref
Crossref
Alexander V. LyubimovRonald E. Savage. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
38
.
Alexander V. LyubimovMichael A. Sinz. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
31
.
Natalia Penner, Lin Xu & Chandra Prakash. (2012) Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies in Drug Development: Why, When, and How?. Chemical Research in Toxicology 25:3, pages 513-531.
Crossref
Crossref
Eric G. Solon. (2012) Use of Radioactive Compounds and Autoradiography to Determine Drug Tissue Distribution. Chemical Research in Toxicology 25:3, pages 543-555.
Crossref
Crossref
Zhuang Miao, Hao Sun, Jennifer Liras & Chandra Prakash. (2012)
Excretion, Metabolism, and Pharmacokinetics of 1-(8-(2-Chlorophenyl)-9-(4-Chlorophenyl)-9
H
-Purin-6-yl)-4-(Ethylamino)Piperidine-4-Carboxamide, a Selective Cannabinoid Receptor Antagonist, in Healthy Male Volunteers
. Drug Metabolism and Disposition 40:3, pages 568-578.
Crossref
Crossref
Alexander V. LyubimovShelby Anderson, Debra Luffer‐Atlas & Mary Pat Knadler. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
27
.
Alexander V. LyubimovThomas A. Baillie. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
24
.
Stephen Castellino, Michael O'Mara, Kevin Koch, David J. Borts, Gary D. Bowers & Christopher MacLauchlin. (2012) Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity. Drug Metabolism and Disposition 40:1, pages 139-150.
Crossref
Crossref
Patrick J. Rudewicz. 2011. Protein and Peptide Mass Spectrometry in Drug Discovery. Protein and Peptide Mass Spectrometry in Drug Discovery
435
447
.
K S Amidon, P Langguth, H Lennernäs, L Yu & G L Amidon. (2011) Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy. Clinical Pharmacology & Therapeutics 90:3, pages 467-470.
Crossref
Crossref
Richard A. Graham, Bert L. Lum, Glenn Morrison, Ilsung Chang, Karin Jorga, Brian Dean, Young G. Shin, Qin Yue, Teresa Mulder, Vikram Malhi, Minli Xie, Jennifer A. Low & Cornelis E. C. A. Hop. (2011) A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry. Drug Metabolism and Disposition 39:8, pages 1460-1467.
Crossref
Crossref
W. Griffith Humphreys. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
229
253
.
Pierre Peeters, Paul Passier, Jean Smeets, Alex Zwiers, Marcel de Zwart, Saskia van de Wetering‐Krebbers, Marlou van Iersel, Sjoerd van Marle & Diels van den Dobbelsteen. (2011) Sugammadex is cleared rapidly and primarily unchanged via renal excretion. Biopharmaceutics & Drug Disposition 32:3, pages 159-167.
Crossref
Crossref
Krista Dobo, Don Walker & Andrew Teasdale. 2011. Genotoxic Impurities. Genotoxic Impurities
151
167
.
Cecilia Renzulli, Mike Nash, Mark Wright, Steven Thomas, Stefano Zamuner, Mario Pellegatti, Paolo Bettica & Gary Boyle. (2011)
Disposition and Metabolism of [
14
C]SB-649868, an Orexin 1 and 2 Receptor Antagonist, in Humans
. Drug Metabolism and Disposition 39:2, pages 215-227.
Crossref
Crossref
Jens Atzrodt & John Allen. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
105
118
.
Ulrich Kuerzel, Volker Krone, Manfred Zimmer & Gareth Shackleton. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
73
103
.
J. Greg Slatter. 2010. Biotransformation and Metabolite Elucidation of Xenobiotics. Biotransformation and Metabolite Elucidation of Xenobiotics
295
312
.
Karthik Venkatakrishnan, Michael D. Pickard & Lisa L. von Moltke. (2010) A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development. Clinical Pharmacokinetics 49:11, pages 703-727.
Crossref
Crossref
Amin Kamel, R. Scott Obach, Kevin Colizza, Weiwei Wang, Thomas N. O'Connell, Richard V. CoelhoJrJr, Ryan M. Kelley & Klaas Schildknegt. (2010)
Metabolism, Pharmacokinetics, and Excretion of the 5-Hydroxytryptamine
1B
Receptor Antagonist Elzasonan in Humans
. Drug Metabolism and Disposition 38:11, pages 1984-1999.
Crossref
Crossref
L Z Benet & C A Larregieu. (2010) The FDA Should Eliminate the Ambiguities in the Current BCS Biowaiver Guidance and Make Public the Drugs for Which BCS Biowaivers Have Been Granted. Clinical Pharmacology & Therapeutics 88:3, pages 405-407.
Crossref
Crossref
Jeng-Pyng Shaw, Jonathan Cheong, Michael R. Goldberg & Michael M. Kitt. (2010)
Mass Balance and Pharmacokinetics of [
14
C]Telavancin following Intravenous Administration to Healthy Male Volunteers
. Antimicrobial Agents and Chemotherapy 54:8, pages 3365-3371.
Crossref
Crossref
Mark N. Milton. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
218
.
Zheng Yang. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
24
.
Sanjeev Kumar, Eugene Y. Tan, Georgy Hartmann, Zachary Biddle, Arthur J. Bergman, James Dru, Jonathan Z. Ho, Allen N. Jones, Steve J. Staskiewicz, Matthew P. Braun, Bindhu Karanam, Dennis C. Dean, Isaias Noel Gendrano, Mark W. Graves, John A. Wagner & Rajesh Krishna. (2010) Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans. Drug Metabolism and Disposition 38:3, pages 474-483.
Crossref
Crossref
C B Frederick & R S Obach. (2010) Metabolites in Safety Testing: “MIST” for the Clinical Pharmacologist. Clinical Pharmacology & Therapeutics 87:3, pages 345-350.
Crossref
Crossref
Volker Derdau, Thorsten Fey & Jens Atzrodt. (2010) Synthesis of isotopically labelled SGLT inhibitors and their metabolites. Tetrahedron 66:7, pages 1472-1482.
Crossref
Crossref
Ragu Ramanathan, S Çömezoglu & W Humphreys. 2009. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition
127
203
.
Manthena V. S. Varma, Bo Feng, R. Scott Obach, Matthew D. Troutman, Jonathan Chupka, Howard R. Miller & Ayman El-Kattan. (2009) Physicochemical Determinants of Human Renal Clearance. Journal of Medicinal Chemistry 52:15, pages 4844-4852.
Crossref
Crossref
Mario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, Andy Roberts & Brendan M. Johnson. (2009) Disposition and Metabolism of Radiolabeled Casopitant in Humans. Drug Metabolism and Disposition 37:8, pages 1635-1645.
Crossref
Crossref
Donglu Zhang, Kan He, Nirmala Raghavan, Lifei Wang, James Mitroka, Brad D. Maxwell, Robert M. Knabb, Charles Frost, Alan Schuster, Feng Hao, Zheming Gu, W. Griffith Humphreys & Scott J. Grossman. (2009)
Comparative Metabolism of
14
C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans
. Drug Metabolism and Disposition 37:8, pages 1738-1748.
Crossref
Crossref
Natalia Penner, Lewis J. Klunk & Chandra Prakash. (2009) Human radiolabeled mass balance studies: objectives, utilities and limitations. Biopharmaceutics & Drug Disposition 30:4, pages 185-203.
Crossref
Crossref
Thomas A. Baillie. (2009) Approaches to the Assessment of Stable and Chemically Reactive Drug Metabolites in Early Clinical Trials. Chemical Research in Toxicology 22:2, pages 263-266.
Crossref
Crossref
Laurent Leclercq, Filip Cuyckens, Geert S. J. Mannens, Ronald de Vries, Philip Timmerman & David C. Evans. (2009) Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical Development. Chemical Research in Toxicology 22:2, pages 280-293.
Crossref
Crossref
Zheng Yang. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
41
64
.
Mark N. Milton. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
783
1000
.
Nirmala Raghavan, Charles E. Frost, Zhigang Yu, Kan He, Haiying Zhang, W. Griffith Humphreys, Donald Pinto, Shiangyuan Chen, Samuel Bonacorsi, Pancras C. Wong & Donglu Zhang. (2009) Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans. Drug Metabolism and Disposition 37:1, pages 74-81.
Crossref
Crossref
Displaying 200 of 202 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list